Results 11 to 20 of about 1,626,022 (379)

Messenger RNA [PDF]

Definitions, 2020
semanticscholar   +3 more sources

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.

Journal of the American Medical Association (JAMA), 2021
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients Immunocompromised individuals have been excluded from studies of SARS-CoV-2 messenger RNA (mRNA) vaccines.
B. Boyarsky, William Werbel, R. Avery, A. Tobian, A. Massie, D. Segev, J. Garonzik‐Wang   +6 more
semanticscholar   +1 more source

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer

JAMA Oncology, 2021
Key Points Question Do patients with cancer develop adequate antibody responses to messenger RNA SARS-CoV-2 vaccines? Findings In this cohort study that included 102 patients with cancer who were receiving active treatment and 78 healthy controls, 92 ...
Amir Massarweh, N. Eliakim‐Raz, A. Stemmer, A. Levy-Barda, S. Yust-Katz, A. Zer, A. Benouaich‐Amiel, H. Ben‐Zvi, N. Moskovits, B. Brenner, J. Bishara, D. Yahav, B. Tadmor, T. Zaks, S. Stemmer   +14 more
semanticscholar   +1 more source

Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS–CoV‐2 Messenger RNA Vaccination

Arthritis & Rheumatology, 2021
To evaluate disease flare and postvaccination reactions (reactogenicity) in patients with rheumatic and musculoskeletal diseases (RMDs) following 2‐dose SARS–CoV‐2 messenger RNA (mRNA) vaccination.
C. Connolly, Jake A. Ruddy, B. Boyarsky, I. Barbur, W. Werbel, Duvuru Geetha, J. Garonzik‐Wang, D. Segev, L. Christopher‐Stine, Julie J. Paik   +9 more
semanticscholar   +1 more source

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant

JAMA Network Open, 2021
This case series study assesses whether a fourth dose of a SARS-CoV-2 messenger RNA (mRNA)–based vaccine is associated with improved anti–SARS-CoV-2 antibody response in solid organ transplant recipients in France.
N. Kamar, F. Abravanel, O. Marion, R. Romieu-Mourez, Chloé Couat, A. Del Bello, J. Izopet   +6 more
semanticscholar   +1 more source

Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine

Cornea, 2021
Purpose: The aim of this report was to report 2 patients who presented with acute corneal graft rejection 2 weeks after receiving the BNT162b2 messenger RNA (mRNA) vaccine for severe acute respiratory syndrome coronavirus 2. Methods: Case report. Results:
L. Wasser, E. Roditi, D. Zadok, Liron Berkowitz, Y. Weill   +4 more
semanticscholar   +1 more source

The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance

Technology in Cancer Research & Treatment, 2020
RNA-binding proteins have been associated with cancer development. The overexpression of a well-known RNA-binding protein, insulin-like growth factor 2 messenger RNA–binding protein 3, has been identified as an indicator of poor prognosis in patients ...
Jing Zhang MS, Fanghui Ding MD, Dan Jiao MS, Qiaozhi Li MS, Hong Ma MS   +4 more
doaj   +1 more source

Pseudo-messenger RNA: phantoms of the transcriptome. [PDF]

PLoS Genetics, 2006
The mammalian transcriptome harbours shadowy entities that resist classification and analysis. In analogy with pseudogenes, we define pseudo-messenger RNA to be RNA molecules that resemble protein-coding mRNA, but cannot encode full-length proteins owing
Martin C Frith, Laurens G Wilming, Alistair Forrest, Hideya Kawaji, Sin Lam Tan, Claes Wahlestedt, Vladimir B Bajic, Chikatoshi Kai, Jun Kawai, Piero Carninci, Yoshihide Hayashizaki, Timothy L Bailey, Lukasz Huminiecki   +12 more
doaj   +2 more sources

From Viral Vaccines to Messenger RNA Vaccines

Pakistan Journal of Medicine and Dentistry, 2020
Today, the swiftness of epidemics of infectious disease is alarming. To date vaccines have been an enormous success for not only preventing but completely eradicating a number of malicious infectious disease like small pox, rubella, mumps, measles and ...
Saeeda Baig, Zoha Asghar
doaj   +1 more source

Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor. [PDF]

, 2016
Rocaglamide A (RocA) typifies a class of protein synthesis inhibitors that selectively kill aneuploid tumour cells and repress translation of specific messenger RNAs.
Floor, Stephen N, Ingolia, Nicholas T, Iwasaki, Shintaro   +2 more
core   +1 more source